Mihran Yenikomshian, MBA, FW

Managing Principal
Analysis Group, Inc., Boston, MA, USA

Poster(s):

• (98) Real-world treatment patterns in patients with psoriasis receiving tildrakizumab compared to ustekinumab
  Wednesday, October 29, 2025